GO:0160121 bis(monoacylglycero)phosphate synthase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0160121 describes the enzymatic activity that synthesizes bis(monoacylglycero)phosphate (BMP), a unique lysosomal phospholipid critical for lipid homeostasis and membrane integrity.
• The Batten disease gene product CLN5 was identified as the lysosomal BMP synthase, directly linking this activity to neurodegeneration.
• BMP metabolism is emerging as a key player in cancer, including hepatocellular carcinoma and therapy-resistant cancers, through pathways involving ATF4/LPLA2 and lysosomal stress responses.
• Enzymes such as PLA2G15 act as lysosomal BMP hydrolases, counterbalancing synthase activity and influencing lysosomal disease progression.
• Dysregulation of BMP synthase activity is implicated in lysosomal storage disorders, neurodegeneration, and cancer, making it a promising therapeutic target.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential tools to dissect the mechanistic roles of BMP synthase and its regulators in health and disease.
Description
Bis(monoacylglycero)phosphate (BMP) is a structurally unique phospholipid found predominantly in the inner membranes of late endosomes and lysosomes, where it plays a critical role in lipid sorting, membrane fusion, and lysosomal function. The enzyme responsible for BMP synthesis, bis(monoacylglycero)phosphate synthase, catalyzes the transfer of an acyl group between two molecules of 3-acyl-sn-glycero-1-phospho-(1'-sn-glycerol), yielding BMP and sn-glycero-1-phospho-(1'-sn-glycerol). This activity, annotated as GO:0160121, is essential for maintaining BMP levels and lysosomal homeostasis. The identification of CLN5 as the lysosomal BMP synthase provided a direct molecular link between BMP metabolism and Batten disease, a fatal neurodegenerative disorder. Subsequent studies have expanded the role of BMP synthase activity to cancer biology, where alcohol-induced ATF4/LPLA2 signaling enhances BMP metabolism and promotes HBV-related hepatocellular carcinogenesis. Additionally, targeting lysosomal HSP70 to modulate sphingomyelin-driven TRPML1 inactivation and TFEB suppression has been shown to overcome ELDR-mediated cancer cell survival, highlighting the therapeutic potential of manipulating BMP pathways. Given its central role in lysosomal lipid metabolism and its implications in neurodegeneration and cancer, understanding the regulation and function of BMP synthase activity is of high research interest. This article provides a comprehensive overview of GO:0160121, covering its definition, molecular mechanism, key genes, disease associations, and state-of-the-art research methods including CRISPR-based models.
bis(monoacylglycero)phosphate synthase activity At A Glance
| GO ID | GO:0160121 |
|---|---|
| GO term | bis(monoacylglycero)phosphate synthase activity |
| Ontology | molecular_function |
| Synonym | None |
| Definition | Catalysis of the reaction: 2 3-acyl-sn-glycero-1-phospho-(1'-sn-glycerol) = 3-acyl-sn-glycero-1-phospho-(3'-acyl-1'-sn-glycerol) + sn-glycero-1-phospho-(1'-sn-glycerol). |
| Major function | Synthesis of bis(monoacylglycero)phosphate (BMP), a lysosomal phospholipid involved in lipid sorting and membrane integrity. |
| Key enzyme | CLN5 (lysosomal BMP synthase). |
| Related diseases | Batten disease, hepatocellular carcinoma, lysosomal storage disorders. |
| Research methods | CRISPR knockout/knock-in, lipidomics, enzymatic assays, imaging. |
What Is GO:0160121?
GO:0160121, bis(monoacylglycero)phosphate synthase activity, is a molecular function defined by the catalytic reaction: 2 3-acyl-sn-glycero-1-phospho-(1'-sn-glycerol) = 3-acyl-sn-glycero-1-phospho-(3'-acyl-1'-sn-glycerol) + sn-glycero-1-phospho-(1'-sn-glycerol). In simpler terms, it is the enzyme activity that produces bis(monoacylglycero)phosphate (BMP) by transferring an acyl chain between two molecules of a lysophospholipid intermediate, releasing glycerophosphoglycerol. This activity is essential for generating BMP, a lipid critical for lysosomal membrane dynamics and function.
Why Is bis(monoacylglycero)phosphate synthase activity Important in Cell Biology?
Bis(monoacylglycero)phosphate synthase activity is fundamentally important because it generates BMP, a phospholipid that is indispensable for lysosomal function and cellular lipid homeostasis. Dysregulation of this activity leads to severe pathological consequences, including neurodegenerative diseases such as Batten disease, where mutations in CLN5 impair BMP synthesis. Moreover, emerging evidence links BMP metabolism to cancer progression, with alcohol-induced ATF4/LPLA2 signaling enhancing BMP production and promoting hepatocellular carcinogenesis. Targeting BMP synthase activity or its regulatory network may therefore offer novel therapeutic strategies for lysosomal disorders and cancer.
• Maintains lysosomal membrane integrity and function by producing BMP, a key lipid for vesicular trafficking.
• Mutations in CLN5, the BMP synthase, cause Batten disease, a fatal neurodegenerative disorder.
• BMP synthase activity is hijacked in alcohol-related hepatocellular carcinoma via ATF4/LPLA2 signaling.
• Modulating BMP levels can overcome therapy resistance in cancer cells through lysosomal stress pathways.
• BMP hydrolases such as PLA2G15 counterbalance synthase activity, and their targeting ameliorates lysosomal disease.
• BMP is essential for cholesterol transport and lipid sorting in endolysosomal compartments.
• The unique stereochemistry of BMP makes it a marker of lysosomal health and a potential biomarker.
• CRISPR screens can identify regulators of BMP synthase activity, uncovering new therapeutic targets.
• Small molecules modulating BMP metabolism are being explored for lysosomal storage disorders.
• Understanding BMP synthase activity provides insights into fundamental membrane biology and disease mechanisms.
What Happens During bis(monoacylglycero)phosphate synthase activity?
Substrate Recognition and Binding
In simple terms: The enzyme grabs two molecules of a lipid called 3-acyl-sn-glycero-1-phospho-(1'-sn-glycerol) to start the reaction.
The BMP synthase, identified as CLN5, is a lysosomal enzyme that recognizes and binds two molecules of the substrate 3-acyl-sn-glycero-1-phospho-(1'-sn-glycerol). This substrate is a lysophospholipid intermediate generated from the breakdown of other lipids. The enzyme's active site accommodates these molecules in a specific orientation to facilitate the subsequent acyl transfer.
Acyl Transfer and Product Formation
In simple terms: The enzyme moves a fatty acid chain from one lipid to the other, creating BMP and a byproduct.
The catalytic mechanism involves the transfer of an acyl chain from one substrate molecule to the other, resulting in the formation of 3-acyl-sn-glycero-1-phospho-(3'-acyl-1'-sn-glycerol), which is BMP, and the release of sn-glycero-1-phospho-(1'-sn-glycerol). This reaction is essential for generating the unique sn-1:sn-1' stereochemistry of BMP, which distinguishes it from other phospholipids.
Lysosomal Localization and Membrane Insertion
In simple terms: The BMP produced is inserted into the lysosomal membrane where it does its job.
BMP synthase activity occurs in the lysosome, where the newly synthesized BMP is directly incorporated into the inner lysosomal membrane. This localization is critical because BMP is required for the proper function of lysosomal enzymes and for the transport of lipids out of the lysosome. CLN5, the enzyme responsible, is targeted to the lysosome via the mannose-6-phosphate pathway or other sorting mechanisms.
Regulation by Lipid Environment and Hydrolases
In simple terms: The reaction is balanced by other enzymes that break down BMP, and the lipid environment affects how well it works.
The activity of BMP synthase is influenced by the local lipid composition and is counterbalanced by BMP hydrolases such as PLA2G15, which degrade BMP. This dynamic regulation ensures appropriate BMP levels for lysosomal function. Dysregulation of either synthase or hydrolase activity can lead to lysosomal dysfunction and disease.
Key Genes Involved in GO:0160121 bis(monoacylglycero)phosphate synthase activity
The following genes and proteins are directly or indirectly involved in bis(monoacylglycero)phosphate synthase activity, its regulation, and its pathophysiological consequences.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CLN5 | Lysosomal BMP synthase; catalyzes BMP synthesis | Mutations cause Batten disease; key target for neurodegeneration research |
| PLA2G15 | Lysosomal BMP hydrolase; degrades BMP | Counterbalances synthase activity; targeting ameliorates lysosomal disease |
| ATF4 | Transcription factor regulating LPLA2 and BMP metabolism | Alcohol-induced ATF4 signaling enhances BMP metabolism in HCC |
| LPLA2 | Lysosomal phospholipase A2; involved in BMP metabolism | Mediates alcohol-induced BMP production in hepatocellular carcinogenesis |
| TFEB | Master transcription factor for lysosomal biogenesis | Suppression via HSP70 targeting affects BMP-related lysosomal function |
| TRPML1 | Lysosomal calcium channel; regulated by sphingomyelin | Inactivation linked to ELDR-mediated cancer survival and BMP pathways |
| HSP70 | Lysosomal chaperone; targets TFEB | Targeting HSP70 modulates lysosomal function and BMP metabolism |
| GBA | Glucocerebrosidase; involved in lipid metabolism | Glucosylated lipids intersect with BMP pathways |
| SMPD1 | Acid sphingomyelinase; produces ceramide | Sphingomyelin-driven TRPML1 inactivation affects BMP-related lysosomal stress |
| NPC1 | Cholesterol transporter; interacts with BMP | BMP is critical for cholesterol egress; NPC1 models used in lysosomal research |
| NPC2 | Cholesterol transporter; interacts with BMP | BMP facilitates cholesterol transfer; relevant to lysosomal storage disorders |
| LAMP1 | Lysosomal membrane protein | Marker for lysosomal integrity in BMP studies |
| LAMP2 | Lysosomal membrane protein | Marker for lysosomal function and BMP localization |
| Rab7 | Late endosome/lysosome trafficking | Regulates lysosomal positioning and BMP distribution |
| V-ATPase | Lysosomal acidification | Required for optimal BMP synthase activity |
| mTORC1 | Regulates lysosomal biogenesis and lipid metabolism | May influence BMP synthase expression and activity |
| CLN3 | Batten disease protein; interacts with CLN5 | Potential modifier of BMP synthase function |
| CLN6 | Batten disease protein; ER-resident | May affect CLN5 trafficking and BMP synthesis |
How Is bis(monoacylglycero)phosphate synthase activity Regulated?
The activity of bis(monoacylglycero)phosphate synthase is regulated at multiple levels. Transcriptionally, the integrated stress response (ISR) and ATF4 can upregulate LPLA2 and BMP metabolism under conditions such as alcohol exposure, as shown in hepatocellular carcinoma models. Additionally, lysosomal biogenesis controlled by TFEB influences the overall capacity for BMP synthesis, and suppression of TFEB via lysosomal HSP70 targeting alters BMP-related pathways. Post-translationally, CLN5 trafficking and activity may be modulated by interactions with other Batten disease proteins such as CLN3 and CLN6. Finally, the balance between BMP synthase and hydrolases like PLA2G15 determines steady-state BMP levels, and this balance is sensitive to lysosomal lipid environment and pH.
bis(monoacylglycero)phosphate synthase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CLN5 | Batten disease (neuronal ceroid lipofuscinosis) | CLN5 knockout neurons; patient iPSC-derived neurons |
| ATF4/LPLA2 | Alcohol-related hepatocellular carcinoma | HCC cell lines with ATF4 knockdown; HBV transgenic mice |
| PLA2G15 | Lysosomal storage disorders | PLA2G15 knockout mice; lysosomal disease cell models |
| HSP70/TRPML1 | Cancer therapy resistance (ELDR) | Cancer cell lines with HSP70 knockout; xenograft models |
| GBA/SMPD1 | Gaucher disease, Niemann-Pick disease | Patient fibroblasts; CRISPR-corrected iPSCs |
Batten Disease and Neurodegeneration
Mutations in CLN5, the gene encoding the lysosomal BMP synthase, cause Batten disease (neuronal ceroid lipofuscinosis), a fatal neurodegenerative disorder characterized by progressive loss of vision, motor decline, and cognitive impairment. Loss of CLN5 function leads to reduced BMP synthesis, lysosomal dysfunction, and accumulation of undegraded lipids, ultimately causing neuronal death. This directly links GO:0160121 to neurodegeneration and highlights the importance of BMP synthase activity for neuronal survival.
Hepatocellular Carcinoma and Alcohol-Related Liver Cancer
Alcohol consumption activates ATF4/LPLA2-mediated BMP metabolism, which enhances HBV-induced hepatocellular carcinogenesis. In this context, increased BMP synthesis supports cancer cell survival and proliferation, suggesting that BMP synthase activity contributes to liver cancer progression. Targeting this pathway may offer therapeutic benefits for alcohol-related HCC.
Lysosomal Storage Disorders and Therapy Resistance
Dysregulation of BMP metabolism is implicated in lysosomal storage disorders and cancer therapy resistance. For example, targeting lysosomal HSP70 to modulate sphingomyelin-driven TRPML1 inactivation and TFEB suppression can overcome ELDR-mediated cancer cell survival, a process that involves BMP pathways. Additionally, PLA2G15, a BMP hydrolase, is a therapeutic target for lysosomal diseases, and its inhibition alters BMP levels. These findings underscore the broad pathological relevance of BMP synthase activity.
From bis(monoacylglycero)phosphate synthase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the catalytic mechanism of CLN5? | Point mutations in CLN5 active site; recombinant protein assays |
| How does loss of BMP synthase affect lysosomal function? | CLN5 knockout cell lines; lipidomics and imaging |
| Can restoring BMP synthesis rescue Batten disease phenotypes? | Knock-in of wild-type CLN5 in patient iPSCs; neuronal differentiation |
| What are the interactors of BMP synthase? | Tagged knock-in of CLN5 (e.g., GFP) for immunoprecipitation |
| Does overexpression of BMP synthase promote cancer? | Overexpression of CLN5 in HCC cell lines; xenograft models |
| How do hydrolases regulate BMP levels? | PLA2G15 knockout and overexpression models; lipidomics |
How to Study the bis(monoacylglycero)phosphate synthase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS lipidomics | BMP species and other lipids | Quantifying BMP levels in cells/tissues |
| Enzymatic activity assay | BMP synthase catalytic rate | Kinetic studies, inhibitor screening |
| CRISPR knockout screen | Genes affecting BMP levels | Identifying regulators of BMP synthesis |
| Fluorescence microscopy | BMP localization and lysosome morphology | Visualizing BMP dynamics |
| Immunoprecipitation | Protein interactors of CLN5 | Discovering BMP synthase complex components |
| RNA-seq | Transcriptional changes in BMP pathway | Assessing ATF4/LPLA2 regulation |
| Proteomics | Protein abundance and modifications | Global effects of BMP synthase perturbation |
| CRISPR activation (CRISPRa) | Overexpression of candidate genes | Testing sufficiency of genes in BMP synthesis |
Lipidomics and Mass Spectrometry
Lipidomics using liquid chromatography-tandem mass spectrometry (LC-MS/MS) is the gold standard for quantifying BMP species and assessing BMP synthase activity in cells and tissues. This method allows researchers to measure the products of GO:0160121 and track changes in response to genetic or pharmacological perturbations.
Enzymatic Activity Assays
In vitro enzymatic assays using recombinant CLN5 or lysosomal extracts with fluorescent or radiolabeled substrates can directly measure BMP synthase activity. These assays are useful for kinetic studies and for testing inhibitors or activators.
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout or activation screens can identify genes that regulate BMP levels or synthase activity. Such screens have the power to uncover novel regulators and therapeutic targets within the BMP pathway.
Imaging and Subcellular Localization
Fluorescence microscopy with BMP-specific probes or tagged CLN5 can visualize BMP distribution and lysosomal morphology. Live-cell imaging allows dynamic tracking of BMP synthesis and trafficking in response to stimuli.
How CRISPR Can Be Used to Study GO:0160121 bis(monoacylglycero)phosphate synthase activity
Knockout
CRISPR knockout of CLN5 or other BMP-related genes (e.g., PLA2G15) in cell lines or primary cells abolishes or reduces BMP synthase activity, allowing researchers to study loss-of-function phenotypes such as lysosomal dysfunction, lipid accumulation, and neurodegeneration. Knockout models are essential for validating the role of GO:0160121 in disease.
Point Mutation
Introducing disease-associated point mutations into CLN5 (e.g., those found in Batten disease patients) via CRISPR base editing or homology-directed repair can reveal how specific residues affect catalytic activity, substrate binding, or protein stability. Such models are invaluable for understanding genotype-phenotype correlations.
Knock-in
Knock-in of wild-type CLN5 or tagged versions (e.g., GFP-CLN5) into a safe locus or the endogenous locus enables rescue experiments and real-time tracking of BMP synthase in live cells. Knock-in models are also used to create isogenic controls for disease studies.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of CLN5 or other BMP pathway genes can elevate BMP synthase activity, useful for studying gain-of-function effects in cancer or for producing large amounts of BMP for biochemical assays. Overexpression models help determine whether increased BMP synthesis drives phenotypes such as tumor growth.
How EDITGENE Supports bis(monoacylglycero)phosphate synthase activity Research
Researchers studying bis(monoacylglycero)phosphate synthase activity-related genes often need to determine whether a candidate gene is causally involved in BMP metabolism, lysosomal function, or disease progression. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and knock-in models, as well as high-throughput library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for bis(monoacylglycero)phosphate synthase activity research.
Frequently Asked Questions About bis(monoacylglycero)phosphate synthase activity
What is bis(monoacylglycero)phosphate synthase activity?
It is the enzymatic activity (GO:0160121) that catalyzes the synthesis of bis(monoacylglycero)phosphate (BMP) from two molecules of 3-acyl-sn-glycero-1-phospho-(1'-sn-glycerol), producing BMP and sn-glycero-1-phospho-(1'-sn-glycerol).
What gene encodes the bis(monoacylglycero)phosphate synthase?
The Batten disease gene product CLN5 encodes the lysosomal BMP synthase.
What diseases are associated with bis(monoacylglycero)phosphate synthase activity?
Mutations in CLN5 cause Batten disease, a neurodegenerative disorder. Dysregulated BMP metabolism is also implicated in hepatocellular carcinoma and lysosomal storage disorders.
How is bis(monoacylglycero)phosphate synthase activity regulated?
It is regulated transcriptionally by ATF4 and TFEB, and balanced by BMP hydrolases such as PLA2G15. Lipid environment and lysosomal pH also influence activity.
What methods are used to study bis(monoacylglycero)phosphate synthase activity?
Common methods include lipidomics (LC-MS/MS), enzymatic activity assays, CRISPR screens, fluorescence microscopy, and immunoprecipitation.
What is the role of BMP in lysosomal function?
BMP is critical for lysosomal membrane integrity, lipid sorting, and cholesterol transport. It is essential for proper lysosomal enzyme function.
Can CRISPR be used to model BMP synthase deficiency?
Yes, CRISPR knockout of CLN5 in cell lines or iPSCs can model Batten disease and study the consequences of loss of BMP synthase activity.
What are the therapeutic implications of targeting BMP synthase?
Modulating BMP levels may treat lysosomal storage disorders and cancer. Targeting hydrolases like PLA2G15 or upstream regulators like ATF4 are promising strategies.
What is the substrate of BMP synthase?
The substrate is 3-acyl-sn-glycero-1-phospho-(1'-sn-glycerol), a lysophospholipid intermediate.
Where in the cell does BMP synthesis occur?
BMP synthesis occurs in the lysosome, where CLN5 is localized.
Conclusion
Bis(monoacylglycero)phosphate synthase activity (GO:0160121) is a fundamental enzymatic function required for the synthesis of BMP, a unique lysosomal phospholipid essential for membrane integrity and lipid homeostasis. The identification of CLN5 as the synthase has linked this activity to Batten disease and opened new avenues for understanding lysosomal biology. Emerging evidence implicates BMP metabolism in cancer and therapy resistance, highlighting its potential as a therapeutic target. Continued research using advanced CRISPR models and lipidomics will further elucidate the regulation and pathophysiological roles of this critical enzyme, paving the way for novel treatments for lysosomal disorders and cancer.
References
- 1. Medoh UN et al.. 2024. The Bis(monoacylglycero)-phosphate Hypothesis: From Lysosomal Function to Therapeutic Avenues.. Annu Rev Biochem 93(1):447-469 PMID: 38603559
- 2. Medoh UN et al.. 2023. The Batten disease gene product CLN5 is the lysosomal bis(monoacylglycero)phosphate synthase.. Science 381(6663):1182-1189 PMID: 37708259
- 3. Zhou H et al.. 2026. Alcohol activates ATF4/LPLA2-mediated BMP metabolism to enhance HBV-induced hepatocellular carcinogenesis.. J Hepatol 84(2):339-354 PMID: 40885211
- 4. Chen H et al.. 2025. Overcoming ELDR-mediated cancer cell survival in vitro and in vivo via sphingomyelin-driven TRPML1 inactivation and TFEB suppression through lysosomal HSP70 targeting.. Pharmacol Res 222:108050 PMID: 41352406
- 5. Ishibashi Y et al.. 2013. New insights on glucosylated lipids: metabolism and functions.. Biochim Biophys Acta 1831(9):1475-85 PMID: 23770033
- 6. Nyame K et al.. 2025. PLA2G15 is a Lysosomal BMP Hydrolase and its Targeting Ameliorates Lysosomal Disease.. bioRxiv PMID: 38895439
